Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Jan 16, 2018 · 10-Q · 47 days after period end · 0001640334-18-000106
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | -$277.06K | -$9.52K | -$15.22K | -$2.00K |
| EPS Diluted | -$0.02 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Nov 30, 2017 · filed Jan 16, 2018 · 47 d after period end
